107,809 Shares in Mobia Medical, Inc. $MOBI Acquired by University of Texas Texas AM Investment Management Co.

University of Texas Texas AM Investment Management Co. acquired a new stake in shares of Mobia Medical, Inc. (NASDAQ:MOBI) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 107,809 shares of the company’s stock, valued at approximately $1,019,000. University of Texas Texas AM Investment Management Co. owned approximately 0.32% of Mobia Medical as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp bought a new position in shares of Mobia Medical in the 2nd quarter worth $735,000. Citadel Advisors LLC acquired a new stake in Mobia Medical in the 2nd quarter valued at $670,000. Finally, Readystate Asset Management LP acquired a new stake in Mobia Medical in the 2nd quarter valued at $134,000.

Mobia Medical Stock Performance

MOBI stock opened at $11.19 on Monday. The company has a debt-to-equity ratio of 0.05, a current ratio of 11.79 and a quick ratio of 11.24. The company’s 50-day moving average is $10.00. The firm has a market cap of $372.52 million and a P/E ratio of -0.55. Mobia Medical, Inc. has a 52-week low of $8.03 and a 52-week high of $15.29.

Mobia Medical (NASDAQ:MOBI) last issued its quarterly earnings data on Thursday, November 5th. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.46) by ($0.06). The company had revenue of $15.62 million during the quarter. Mobia Medical had a negative return on equity of 2,198.27% and a negative net margin of 135.03%. Mobia Medical’s quarterly revenue was up 73.3% compared to the same quarter last year. As a group, sell-side analysts forecast that Mobia Medical, Inc. will post -2.63 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Casey Tansey purchased 35,572 shares of the firm’s stock in a transaction that occurred on Thursday, August 13th. The stock was acquired at an average price of $11.51 per share, for a total transaction of $409,433.72. Following the completion of the acquisition, the director owned 268,904 shares of the company’s stock, valued at $3,095,085.04. This represents a 15.25% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders purchased a total of 87,000 shares of company stock worth $1,016,367 over the last 90 days.

Analyst Upgrades and Downgrades

A number of brokerages have commented on MOBI. JPMorgan Chase & Co. boosted their price target on shares of Mobia Medical from $15.00 to $17.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Weiss Ratings initiated coverage on shares of Mobia Medical in a research note on Wednesday, August 12th. They issued a “sell (e-)” rating on the stock. Finally, BTIG Research reiterated a “buy” rating and set a $20.00 price objective on shares of Mobia Medical in a report on Friday. Five research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Mobia Medical has a consensus rating of “Moderate Buy” and a consensus target price of $21.00.

Mobia Medical Company Profile

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.